Tag Archives: Cannabis Act

Health Canada’s Proposed Cannabis Act – Bill C-45

cannabis flag

The second of three readings of Bill C-45 – “An Act respecting the legal access to cannabis and the control of its production, distribution and sale”, was still being debated in parliament, before the summer break.

The latest publication of the Cannabis Act is from the first reading and the stated objectives are “to prevent young persons from accessing cannabis, to protect public health and public safety by establishing strict product safety and product quality requirements …”

The debate in the second reading stems around the Canadian Medical Association (CMA)’s outburst that “legalizing weed will harm youth”.  In addition, other Big Pharma supporters, such as the editor in chief of the Canadian Medical Association Journal stating that the new legislation is not protecting Canada’s youth.

Other Big Pharma supporters, such as Health Canada, claim that not enough research and scientific evidence exists on the safety of cannabis.

A study by the institute for Clinical Evaluative Sciences found that an alarming number of school age youth have been diagnosed with ADHD and prescribed harmful antipsychotic drugs.

The Diagnostic & Statistical Manual (DSM 5) is the basis for the listing of mental disorders in the International Classification of Diseases and is used throughout the world. Most of the disorders contained in this manual are said to be caused by a chemical imbalance in the brain.

According to the Citizens Commission on Human Rights (CCHR), the theory that mental disorders are caused by a chemical imbalance in the brain is just an unproven opinion, not fact, since mental disorders are determined by votes, not science. Furthermore, “Governments, insurance companies and private individuals pay billions of dollars each year to psychiatrists in pursuit of cures that psyhiatrists admit do not exist”.

Numerous strains of cannabis have the medicinal health benefits of relieving anxiety, stress, depression and insomnia without any harmful side effects.  In fact, GW Pharma has filed numerous patents on the medicinal benefits of cannabinoids for mental health disorders and a number of diseases, including cancer.

Although prescription bensodiazepines (diazepam, doral, xanax, valium, ativan, etc), used to treat a number of mental disorders, are a leading cause of death in Canada, cannabis has the ability to replace a number of these prescription pills – without harmful side effects.

When doing your own research on the medicinal benefits of cannabis, there is the Big Pharma side vs. Mother Nature. You decide.